Diagnostic quality in hysterosalpingography: Comparison between iodixanol and iotrolan

Acta Radiologica

Volumn 39, Issue 6, 1998, Pages 730-733

  Lindequist, Steen ^a,d   Rasmussen, F ^b   Torp Madsen, H H ^b   Naeser A ^b   Bjartveit, K ^c   Kristoffersen, D T ^c   Klaveness, A J ^c  

^a University of Esbjerg   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c NYCOMED IMAGING AS   (Norway)

^d ESBJERG HOSPITAL   (Denmark)

Author keywords

Comparative studies; Contrast media; Fallopian tubes; Hysterosalpingography; Sterility; Uterus

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; IODIXANOL; IODOBENZOIC ACID DERIVATIVE; IOTROLAN;

ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FEMALE INFERTILITY; HUMAN; HYSTEROSALPINGOGRAPHY; INJECTION; METHODOLOGY; PATHOLOGY; PHASE 3 CLINICAL TRIAL; QUESTIONNAIRE; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; SAFETY; STANDARD; UTERINE TUBE; UTERUS;

CONTRAST MEDIA; DOUBLE-BLIND METHOD; FALLOPIAN TUBES; FEMALE; HUMANS; HYSTEROSALPINGOGRAPHY; INFERTILITY, FEMALE; INJECTIONS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SAFETY; TRIIODOBENZOIC ACIDS; UTERUS;

EID: 0032209825     PISSN: 02841851     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841859809175507     Document Type: Article

References (27)

1. BJERCKE S. & PURVIS K.: Characteristics of women under infertility investigation with IgA/IgG seropositivity for Chlamydia trachmatis. Eur. J. Obstet. Gynecol. Reprod. Biol. 51 (1993), 157.
2. BROKENSHA C. & WHITEHOUSE G.: A comparison between iotrolan, a non-ionic dimer, and a hyperosmolar contrast medium, Urografin, in hysterosalpingography. Br. J. Radiol. 64 (1991), 587.
3. DAVIES A. C., KEIGHTLEY A., BORTHWICK-CLARKE A. & WALTERS H. L.: The use of low-osmolality contrast medium in hysterosalpingography. Comparison with a conventional contrast medium. Clin. Radiol. 36 (1985), 533.
4. JOHNSEN R. A. & WICHERN D. W.: Applied multivariate statistical analysis. Prentice-Hall International Editions, 3rd edn., 1982.
5. KROMANN-ANDERSEN H.: Forsinkede overfølsomhedsreaktioner efter ikke-ioniske dimere røntgenkontraststoffer. (In Danish.) Ugeskr. Læger 159 (1997), 1781.
6. KRYSIEWICZ S.: Infertility in women. Diagnostic evaluation with hysterosalpingography and other imaging techniques. AJR 159 (1992), 1781.
7. LARSEN S., AABAKKEN L., LILLEVOLD P. E. & OSNES M.: Assessing soft data in clinical trials. Pharmaceut. Med. 5 (1991), 29.
8. LINDEOUIST S., JUSTESEN P., LARSEN C. & RASMUSSEN F.: Diagnostic quality and complications of hysterosalpingography. Oil- versus waler-soluble contrast media - a randomized prospective study. Radiology 179 (1991), 69.
9. LINDEQUIST S., RASMUSSEN F. & LARSEN C.: Use of iotrolan versus ethiodized poppy-seed oil in hysterosalpingography. Radiology 191 (1994), 513.
10. LINDSEY D. H., TROUNSON A. O. & ANDERSEN A. N.: Female infertility. Causes and treatment. Lancet 343 (1994), 1539.
11. MEASDAY B.: An analysis of the complications of hysterosalpingography. J. Obstet. Gynaec. Br. Emp. 67 (1960), 663.
12. MIKKONEN R., KONTKANEN T. & KIVISAARI L.: Acute and late adverse reactions to low-osmolal contrast media. Acta Radiol. 36 (1995), 72.
13. MOORE D. E.: Pain associated with hysterosalpingography. Ethiodol versus salpix media. Fertil. Steril. 38 (1982), 629.
14. NIENDORF H. P.: Delayed allergy-like reactions to X-ray contrast media. Eur. Radiol. 6 (Suppl.) (1996), 8.
15. PITTAWAY D. E., WINUELD A. C., MAXON W., DANIELL J., HERBERT C. & WENTZ A. C.: Prevention of acute pelvic inflammatory disease after hysterosalpingography. Efficacy of doxycycline prophylaxis. Am. J. Obstet. Gynecol. 147 (1983), 623.
16. RAJAH R., MCHUGO J. M. & OBHRAI M.: The role of hysterosalpinaography in modern gynaecological practice. Br. J. Radiol. 65 (1992), 849.
17. RASMUSSEN F., LINDEQUIST S., LARSEN C. & JUSTESEN P.: Therapeutic effect of hysterosalpingography. Oil- versus water-soluble contrast media - a randomized prospective study. Radiology 179 (1991), 75.
18. RASMUSSEN F., LINDEQUIST S., MØLLER NIELSEN S. & BJARTVEIT K.: Renal CT after intravenous injection of non-ionic dimeric or nonionic monomeric contrast media in healthy volunteers. Acta Radiol. 38 (1997), 61.
19. SCHUITEMAKER N. W., HELMERHORST F. M., TJON R. T. O. & VAN SAASE J. L. C.: Late anaphylactic shock after hysterosalpingography. Fertil. Steril. 54 (1990), 535.
20. SIEGLER A. M.: Dangers of hysterosalpingography. Obstet. Gynecol. Surv. 22 (1967), 284.
21. SOULES M. R. & SPADONI L. R.: Oil versus aqueous media for hysterosalpingography. A continuing debate based on many opinions and few facts. Fertil. Steril. 38 (1982), 1.
22. STUMPF P. G. & MARCH C. M.: Febrile morbidity following hysterosalpingography. Identification of risk factors and recommendations for prophylaxis. Fertil. Steril. 33 (1980), 487.
23. WATSON A., VANDEKERCKHOVE P., LILFORD R., VAIL A., BROSENS I. & HUGHES E.: A metaanalysis of the therapeutic role of oil soluble contrast media at hysterosalpingography. A surprising result. Fertil. Steril. 61 (1994), 470.
24. WINFIELD A. C., MAXON W. S., HARDING D. R., DIGGS J. & WENTZ A. C.: Hexabrix as a contrast agent for hysterosalpingography. Radiology 152 (1984), 232.
25. WOLF G. & FITZAL P.: Hysterosalpingography with a new contrast medium. In: Recent developments in non-ionic contrast media. Edited by V. Taenzer & S. Wende. Georg Thieme Verlag, Stuttgart 1989.
26. YODER I. C. & DEBORAH A. H.: Hysterosalpingography in the 1990s. AJR 157 (1991), 675.
27. YOSHIKAWA H.: Late adverse reactions to nonionic contrast media. Radiology 183 (1992), 737.